Clinical Trials Browser

Optic Nerve Glioma × antineoplaston AS 2-1 × Clear all

NCT01260103 2017-07-26

Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

Phase 3 Withdrawn

Recurrence, Optic Nerve Glioma